Stanka Stoeva

Stanka Stoeva

Auto-generated profile, based on publicly available information

Stanka Stoeva

Department of Physical Biochemistry, Institute of Physiological Chemistry, University of Tuebingen, Hoppe-Seyler-Strasse 4, D-72076 Tuebingen, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1999 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
WGWolfgang Gebauer
Wolfgang Gebauer
SSStanka Stoeva
Stanka Stoeva
WVWolfgang Voelter
Wolfgang Voelter
EDEnrico Dainese
Enrico Dainese
BSBenedetto Salvato
Benedetto Salvato
JMJürgen Markl
Jürgen Markl

11 November 1999 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
SSStanka Stoeva
Stanka Stoeva
JSJürgen Schütz
Jürgen Schütz
WGWolfgang Gebauer
Wolfgang Gebauer
THTonia Hundsdörfer
Tonia Hundsdörfer
CMChristine Manz
Christine Manz
WVWolfgang Voelter
Wolfgang Voelter

1 January 1998 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
PDF file
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis
IVIoannis F. Voutsas
Ioannis F. Voutsas
MSMontserrat Huguet Soler
Montserrat Huguet Soler
AGAngelas D. Gritzapis
Angelas D. Gritzapis
OTOrania E. Tsitsilonis
Orania E. Tsitsilonis
MPMichail Papamichail
Michail Papamichail
This report demonstrates that in vitro activation of human cells with the beta-galactoside-specific lectin from mistletoe (ML-I) or interleukin-2 (IL-2) results in different patterns of activation and function of cytotoxic cells. It is now well established that natural killer (NK) and lymphokine-activated killer (LAK) cytotoxicity is mainly mediated by resting (NK) and IL-2-activated (LAK) CD56-positive (+) cells respectively. Culture of peripheral blood lymphocytes (PBL) for 3 days with ML-I led to expansion and activation of T cells which demonstrated NK- and LAK-like cytotoxicity. T lymphocyte subset analysis revealed that in total PBL, ML-I preferentially stimulated and expanded CD8+ T cells which mediated the cytotoxic effect. Incubation of highly purified CD8+ T cells alone with ML-I did not lead to induction of cytotoxicity, which required the presence of both CD4+ and CD14+ (monocytes) cells, suggesting that ML-I does not exert a direct effect on CD8+ T cells. Activation of PBL with both ML-I and IL-2 resulted in simultaneous induction of T and CD56+ cell-mediated NK and LAK cytotoxicity. These data suggest that treatment with ML-I and IL-2 might provide an approach to induce maximum cytotoxicity against tumors and to recruit both T and NK cells for tumor therapy.

1 March 2002 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SSStanka Stoeva
Stanka Stoeva
KIKrasimira Idakieva
Krasimira Idakieva
CBChristian Betzel
Christian Betzel
NGNicolay Genov
Nicolay Genov
WVWolfgang Voelter
Wolfgang Voelter

19 June 2000 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
KIKrassimira Idakieva
Krassimira Idakieva
SSStanka Stoeva
Stanka Stoeva
KPKatja Pervanova
Katja Pervanova
NGNicolay Genov
Nicolay Genov
WVWolfgang Voelter
Wolfgang Voelter

1 August 2001 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SSStanka Stoeva
Stanka Stoeva
MFMirita Franza
Mirita Franza
RWRoland Wackera
Roland Wackera
RKRuth Krauspenhaarb
Ruth Krauspenhaarb
EGEckhart Guthöhrleinb
Eckhart Guthöhrleinb
WVWolfgang Voeltera
Wolfgang Voeltera